US2018294049A1
|
|
Opiate reduction treatment system
|
US2018193284A1
|
|
Transdermal cream containing immunomodulators and imiquimod
|
WO2019069114A1
|
|
Individually customized allergy cream for individual patient profile
|
WO2017216633A1
|
|
Method and apparatus for completing prescription for allergen cocktail with patch
|
US2017340576A1
|
|
Method and apparatus for completing prescription for allergen cocktail with patch
|
WO2017137847A1
|
|
Method and system to produce "prick test" single use sterile vials
|
US2017224267A1
|
|
Prick test single use sterile vial and method
|
WO2017134532A1
|
|
Regional allergen testing kit and method
|
WO2017060774A1
|
|
Individually customized allergy cream for individual patient profile
|
US2017039346A1
|
|
Individually customized allergy cream for individual patient profile
|
US2016371445A1
|
|
Method for repurposing NDC codes in a pharmaceutical database for venom derived allergens involved in venom immunotherapy
|
WO2017025812A1
|
|
Method for repurposing ndc codes in a pharmaceutical database for venom derived allergens involved in venom immunotherapy
|
US2017027494A1
|
|
Prick test kit
|
US2016367437A1
|
|
Therapeutic treatment kit for allergies based on DNA profiles
|
US2016368626A1
|
|
Predilution sets for distributing antigens
|
US2016364738A1
|
|
Predictive tracking system for use data in the antigen supply chain to define manufacturing required levels
|
US2016362205A1
|
|
Use of autoinjector for distributing antigens to the public
|
US2017024526A1
|
|
Method for managing reimbursements for previously non database allergens
|
US2015290129A1
|
|
Method for delivery of immunomodulators to a patient
|